Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05177120
Other study ID # 06.12.2019.1053
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2021
Est. completion date August 3, 2022

Study information

Verified date December 2021
Source Marmara University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Familial Mediterranean Fever (FMF) is an autosomal recessive inherited disease with a course of autoinflammation, which is characterized by the episodes of fever and serositis. Central sensitization (CS) is defined as increased response to normal or sub-threshold stimuli of central nervous system and its close relationship with many rheumatological diseases has been demonstrated in several studies. However, there are no data on the frequency of CS in FMF patients.


Description:

Familial Mediterranean fever (FMF) is a self-limiting autoinflammatory disease with well-defined genetic and clinical features. Recurrent episodes of fever and serositis accompanied by increased acute phase reactants and good response to colchicine are the core components of the disease. The frequency of this disease, which is common in Eastern Mediterranean countries, is variable according to regions, but it is reported as 1/1000. In the pathogenesis of the disease, the mutation of the MEFV (Mediterranean Fever) gene, which is located on the 16th chromosome and encodes the pyrin protein, is known as the basic mechanism.In rheumatic diseases, inflammatory mediators cause CS by first creating changes in the regulation of pain in peripheral neurons and then in spinal and supraspinal pathways. Stimulation of peripheral nerves by mediators released during inflammation results in neurogenic inflammation, which is among the peripheral sensitization (PS) mechanisms. PS is defined as the increased sensitivity of nociceptive neurons to normal or below-threshold stimuli and constitutes the first step in the development of CS.Similar to other autoimmune diseases, it is possible that the neuroinflammatory process triggers peripheral and central sensitization mechanisms in FMF patients and affects pain pathways.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date August 3, 2022
Est. primary completion date April 10, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Agree to participate in the study Exclusion Criteria: - Had another systemic inflammatory rheumatic diseases - Using centrally acting pain medications (e.g., pregabalin, duloxetine, opioids) or glucocorticoids (>10 mg prednisone or its equivalent)

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Central Sensitization Inventory
Standardized questionnaire to determine the level of central sensitization
Other:
Short form-36
Standardized questionnaire to investigate the quality of life in patients
Pittsburgh Sleep Quality Index
Standardized questionnaire to investigate the sleep quality and disturbance
Health assessment questionnaire
Standardized questionnaire used to detect the presence of disability
Hospital anxiety and depression scale
Standardized questionnaire to investigate the depression and anxiety
Diagnostic Test:
Fibromyalgia rapid screening tool
Standardized questionnaire to determine the presence of fibromyalgia
Other:
Familial Mediterranean Fever Quality of life scale
Standardized questionnaire to investigate the quality of life in Familial Mediterranean Fever patients

Locations

Country Name City State
Turkey Feyza Nur Yücel Sinop

Sponsors (1)

Lead Sponsor Collaborator
Marmara University

Country where clinical trial is conducted

Turkey, 

References & Publications (11)

Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997 Aug 22;90(4):797-807. — View Citation

Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69-77. Review. — View Citation

Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. — View Citation

Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005 Jan;84(1):1-11. doi: 10.1097/01.md.0000152370.84628.0c. — View Citation

Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009 Sep;10(9):895-926. doi: 10.1016/j.jpain.2009.06.012. Review. — View Citation

Lee YC, Bingham CO 3rd, Edwards RR, Marder W, Phillips K, Bolster MB, Clauw DJ, Moreland LW, Lu B, Wohlfahrt A, Zhang Z, Neogi T. Association Between Pain Sensitization and Disease Activity in Patients With Rheumatoid Arthritis: A Cross-Sectional Study. Arthritis Care Res (Hoboken). 2018 Feb;70(2):197-204. doi: 10.1002/acr.23266. Erratum in: Arthritis Care Res (Hoboken). 2020 Apr;72(4):599. — View Citation

Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, Perez Y, Gatchel RJ. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012 Apr;12(4):276-85. doi: 10.1111/j.1533-2500.2011.00493.x. Epub 2011 Sep 27. — View Citation

Pinar R. Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res. 2005 Feb;14(1):259-64. — View Citation

Senerdem N, Gül A, Koniçe M, Aral O, Ocal L, Inanç M, Yüzbasioglu N. The use of two different Health Assessment Questionnaires in Turkish rheumatoid arthritis population and assessment of the associations with disability. Clin Rheumatol. 1999;18(1):33-7. — View Citation

Silva RL, Lopes AH, Guimarães RM, Cunha TM. CXCL1/CXCR2 signaling in pathological pain: Role in peripheral and central sensitization. Neurobiol Dis. 2017 Sep;105:109-116. doi: 10.1016/j.nbd.2017.06.001. Epub 2017 Jun 3. Review. — View Citation

Unal-Ulutatar C, Duruoz MT. Development and validation of a quality of life scale in Familial Mediterranean Fever (FMFQoL). Mod Rheumatol. 2021 May;31(3):710-717. doi: 10.1080/14397595.2020.1775946. Epub 2020 Jun 26. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Central Sensitization Inventory (CSI) 25 somatic and psychosocial symptoms, which are frequently found in patients with central sensitization in part A, are questioned. In part B, the presence of diseases whose relationship with central sensitization is well defined is questioned in the patient without participating in scoring. Central sensitization is assumed in patients who score 40 or more over 100 points. 6 months
Secondary Short form-36 (SF-36) The 36-Item Short Form Survey (SF-36) is an oft-used, well-researched, self-reported measure of health.The scale consists of 36 questions questioning 8 sub-parameters regarding the health status of the person.These parameters are physical function, pain, limitation due to physical and emotional problems, emotional well-being, social function, fatigue and general health perception. High scores are associated with improved quality of life. 6 months
Secondary Familial Mediterranean Fever Quality of Life Scale (FMF-QoL) FMF-QoL was developed to evaluate the quality of life in FMF patients. This scale consists of 20 questions in the form of a Likert scale and the total scoring is between 0-80. High scores indicate a decrease in quality of life. 6 months
Secondary Health Assessment Questionnaire (HAQ) n the scale, difficulty in performing 20 specific tasks from 8 categories is questioned and the scoring is between 0-60. High scores are associated with increased disability. 6 months
Secondary Hospital Anxiety and Depression Scale (HADS) This scale consists of 14 questions in total, and anxiety symptoms are questioned in half of the questions and depression-related complaints in the other half. A subscore of 8 or higher for depression or anxiety is considered a clinical case. 6 months
Secondary Pittsburgh Sleep Quality Index (PSQI) The questionnaire includes 21 questions covering 7 components that investigate the symptoms of sleep disturbances. Scores range from 0 to 21 and a score of >5 is considered as a sleep disorder. 6 months
Secondary Fibromyalgia Rapid Screening Tool (FIRST). This scale consists of 6 questions investigating the most relevant clinical features of fibromyalgia. The questions are answered as yes/no and 5 or more out of 6 points in total are in favor of fibromyalgia. 6 months
See also
  Status Clinical Trial Phase
Completed NCT06139120 - The Segmental Distribution of Hypersensitivity in Patients With Chronic Subacromial Pain Syndrome
Completed NCT05062694 - Physical Therapy Management Of The Patient With Central Sensitization
Not yet recruiting NCT05986513 - Brain MRI for Knee OA N/A
Not yet recruiting NCT04542798 - CRF vs WCRF or PRF-DRG in CLBP of FJ Origin and RFA Failure of MBDR: Central Sensitization and Aberrant Nerve Sprouting N/A
Completed NCT05559021 - What Concept of Manual Therapy is More Effective? N/A
Completed NCT04485078 - Investigation of Central Sensitization Frequency and Related Factors in Axial Spondyloarthritis Patients
Completed NCT05162664 - Presence of Signs of Central Sensitization in Episodic and Chronic Migraine N/A
Recruiting NCT06043141 - Investigation of the Relationship Between Pain Sensitization and Diagnostic Parameters in Carpal Tunnel Syndrome
Completed NCT06336278 - Relationship Between Central Sensitization and Kinesiophobia in Knee Osteoarthritis
Terminated NCT05022251 - Identifying Pain Generators and Potentiators of Residual Complaints Following Lumbar Discectomy
Completed NCT04361149 - Motor Unit Abnormalities After Experimentally Induced Sensitization Phase 4
Completed NCT05146960 - Relation Between Temporal Summation and Fatigue N/A
Completed NCT04043962 - Mechanisms Of Change in Adolescent Pain Self-management N/A
Completed NCT03863808 - Effect of Cognitive Behavioral Therapy on Chronic Low Back Pain With Sensitization N/A
Active, not recruiting NCT05169918 - Sensorial Discrimination in Chronic Low Back Pain N/A
Completed NCT03531385 - Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease
Recruiting NCT06169917 - Pain Processing In Relation To Breathing N/A
Not yet recruiting NCT06367998 - Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair Phase 4
Completed NCT05932433 - Effectiveness of Therapeutic Exercise on the Gut Microbiome in Chronic Widespread Pain Patients. N/A
Completed NCT05381012 - Fibromyalgia Syndrome on Patients With Chronic Migraine N/A